Arcus Biosciences Inc

NYSE:RCUS   3:59:57 PM EDT
33.05
-0.62 (-1.84%)
4:00:00 PM EDT: $33.02 -0.03 (-0.09%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.36B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$9.71 Million
Adjusted EPS-$1.03
See more estimates
10-Day MA$33.94
50-Day MA$33.03
200-Day MA$31.71
See more pivots

Arcus Biosciences Inc Stock, NYSE:RCUS

3928 Point Eden Way, Hayward, California 94545
United States of America
Phone: +1.510.694.6200
Number of Employees: 236

Description

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.